Direct supply line from our cGMP synthesis hub to pharmaceutical formulation complexes across Mexico City, Tlalpan, and the Toluca-Lerma industrial corridor.
The Metropolitan Area of Mexico City (CDMX) represents Latin America's primary nexus for generic pharmaceutical licensing, sterile manufacturing, and biotherapeutic commercialization.
With type-2 diabetes and obesity reaching critical health priorities across Mexico, localized demand for GLP-1, GIP, and dual-incretin receptor agonists is surging exponentially. Manufacturers in the CDMX area require robust, non-infringing generic peptide bulk supplies to satisfy local healthcare institutions (IMSS, ISSSTE) and commercial retail markets.
Navigating the Federal Commission for Protection Against Sanitary Risks (COFEPRIS) requires transparent analytical characterization. Generic peptide dossiers demand exhaustive impurity profiling (deletion, insertion, and diastereomeric sequences) and valid Drug Master File (DMF) packages to clear NOM-059-SSA1-2015 and NOM-164-SSA1-2015 standards.
Pharmaceutical clusters spanning Mexico City, Cuernavaca, and Querétaro are active nearshoring destinations for North and South American distribution. Securing dependable API flow from automated, large-scale synthesis centers protects Mexican formulators against supply chain shocks and acute raw material shortages.
Leveraging nearly two decades of peptide synthesis mastery to support international industrial scale-up with verifiable multi-ton production power.
Engineered for sequences exceeding 30 to 45 amino acids. Our automated solid-phase platforms precisely govern temperature, coupling kinetics, and deprotection phases, suppressing epimerization and maximizing yield for complex molecules like Semaglutide and Tirzepatide.
Multi-stage DAC (Dynamic Axial Compression) prep columns combined with ultrafiltration units achieve pharmaceutical-grade purity (typically ≥99.0%). Rigorous counter-ion exchange guarantees low, controlled levels of TFA or exact Acetate stoichiometry.
We generate comprehensive CTD-format documentation, stability testing under Zone IVb climatic conditions (essential for Mexico and Central America), validated analytical testing procedures, and bioburden/endotoxin controls for parenteral integration.
Lyophilized peptides represent temperature-sensitive active pharmaceutical ingredients demanding validated logistics across transcontinental routes.
Shipments destined for Mexico City's airports (MEX and NLU/AIFA) are enclosed in certified vacuum-insulated passive cooling containers with continuous GPS and temperature dataloggers (-20°C or 2-8°C ranges), preserving critical secondary and tertiary folding structures.
Peptide importation via Mexican customs (Aduanas) requires rigorous documentation including sanitary registration references, precursor non-classification certificates, Certificates of Origin, and complete commercial packing lists. Our export desk liaises directly with your local broker.
Our international support structure provides bilingual regulatory and technical communication, coordinating batch reservation, validation lot scheduling, and audit coordination for QA inspectors stationed in Mexico or Latin American corporate centers.
Request sample lots, Certificate of Analysis (CoA) batches, or schedule a technical audit with our chemical synthesis team.
Full-spectrum access to validated peptide actives: anti-obesity peptides, gut health regulators, regenerative sequences, and cosmeceutical actives.
Key information regarding analytical specifications, regulatory filings, cold chain logistics, and production audits.
We provide full Drug Master File (open/applicant part) technical packages aligned with NOM-059 and NOM-164 guidelines, including route of synthesis, impurity tracing, structural elucidation (MS, 1H/13C NMR), method validation, and real-time/accelerated stability documentation under ICH climatic Zone IVb conditions.
Our standard generic peptide APIs exhibit HPLC chromatographic purity ≥98.0% or ≥99.0%, with individual unknown impurities controlled below 0.10%. We control residual TFA rigorously, offering Acetate conversion salts with precise stoichiometric content depending on formulation requirements.
In-stock analytical and commercial validation lots dispatch via express temperature-controlled air freight within 48 to 72 hours, typically reaching Mexico City Benito Juárez International Airport (MEX) or Felipe Ángeles (AIFA) within 4 to 6 business days, accompanied by complete batch documentation.
Yes. We welcome QA and compliance audits by Mexican pharmaceutical sponsors and third-party qualified auditors. Virtual video audits and document verification can be scheduled through our international desk to verify our quality management system and synthesis equipment.
Thin